Share tips of the week
MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
Three to buy
Superdry
(The Sunday Telegraph) Superdry’s share price has tripled in less than a year. The group “is reinventing itself”: the products’ quality and style have been improved; it has “done some canny marketing” to appeal to a wider variety of customers; and managers have also concentrated on boosting internet sales, which grew by 34% in the year to April. “Progress on so many fronts reassures us that the share price recovery is built on solid foundations.” 394p
Trident Royalties
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
(The Mail on Sunday) Copper was trading at around $4,500 per tonne a year ago, but over the past few days its price has eclipsed $10,000 and it should keep rising. Metals are booming as economies begin to recover from Covid-19 and governments prepare to increase spending on infrastructure. Trident’s business is mining-royalty finance, whereby firms lend money to miners and receive a percentage of their revenues in return. Trident has already signed seven royalty agreements on iron, copper, gold and lithium. An eighth transaction “is expected imminently”. The variety of metals tempers Trident’s overall exposure to price fluctuations. 34p
Avon Rubber
(Investors’ Chronicle) Protective equipment specialist Avon Rubber’s shares reached a record peak in December, but nosedived two weeks later after it announced delays to two of its US contracts. But the firm has since released two positive trading updates, and has reported “positive momentum” in its second quarter. The group expects sales for the six months to 31 March to jump by two-fifths year-on-year to $122m, and it has “continued to secure more orders”. 3,328p
Three to sell
Calyxt
(Nasdaq) Calyxt uses gene-editing technology to alter living plant cells. The company took nine years to launch its first product: soybean seeds producing cooking oil that doesn’t degrade as fast as regular soybean oil. But it hasn’t been able to sell the seeds at a “viable price” and is still a “long way from earning any money for its investors”. The firm has several modified agricultural products in its pipeline, but investors should wait for proof that it can sell at least one of them at a profit. Avoid. $4.34
Peloton
(Forbes) Peloton shares have dropped by 50% since peaking in December, but the stock is still not a bargain. The firm has had to recall its treadmill, Tread+, after the US Consumer Product Safety Commission urged users with children and pets to stop using it, citing dozens of injuries and at least one death. The recall, which CEO John Foley dragged his feet over, “introduces considerable uncertainty into its revenue growth”. Reopening gyms, meanwhile, may dent demand for Peloton’s exercise bikes. Avoid. $83.81
EKF Diagnostics
(The Sunday Times) EKF Diagnostics specialises in “point of care” tests that allow physicians to find out in real time whether patients are suffering from conditions like anaemia, diabetes or sepsis. It has thrived throughout the pandemic as it makes sample collection kits that keep the virus “inactivated” in the tube, avoiding contamination. It supplies Public Health England and the Irish government. But can it keep up the momentum? Covid-19-related sales accounted for 40% of last year’s revenue, but beyond that “sales have fallen short”. Investors should “take profits”. 70p
...and the rest
Investors’ Chronicle
Fast-fashion retailer Boohoo has benefited from high street closures and a rise in online sales. It is investing heavily in future growth but has still managed to bolster its net cash. It looks set to “continue as an e-commerce fashion winner”. Hold (317p). WHSmith struggled throughout the pandemic but it has announced over 100 new travel stores, and much of that new business stems from North America, which is opening up “far quicker than the UK”. Hold (1,827p).
The Daily Telegraph
There are still plenty of bargains in the British stockmarket, especially for those “willing to be brave and invest in businesses and industries that remain out of favour”. Shares in International Airlines Group are trading at 210p, down from 400p, but it “could return to its pre-Covid-19 profit margin levels as soon as 2023”.
The Mail on Sunday
Increased government spending on infrastructure bodes well for Hill & Smith, the UK’s leading supplier of road-safety barriers. Though its business dipped in 2020, analysts expect figures to bounce back this year and next, with profits of £75m forecast for 2021, rising to £82m in 2022. Buy (1,578p).
Shares
Shares in medical-products firm Convatec have picked up after a slow start to the year. Sales rose by 8.7% in the first quarter of 2021 and the outlook for the remainder of 2021 is encouraging. Buy (205p). Eyewear frames designer Inspecs’ shares are up by 50% in five months. They look poised to keep profiting from pent-up demand and the overall market recovery. Keep buying (404p).
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
Hargreaves Lansdown slashes fees for ISA and SIPP investors - how does it compare to other providers?
Hargreaves Lansdown, the UK’s biggest investment platform, has dropped its fees by 40%, to their lowest ever level, for certain customers. Is it a good deal, and how does it compare to other providers?
By Ruth Emery
-
BP's 'long, painful decline' – and why next year could be even tougher
Opinion Long-suffering shareholders in oil giant BP have been pushing for change. It won’t come soon enough, says Matthew Lynn
By Matthew Lynn
-
BP's 'long, painful decline' – and why next year could be even tougher
Opinion Long-suffering shareholders in oil giant BP have been pushing for change. It won’t come soon enough, says Matthew Lynn
By Matthew Lynn
-
Investment trusts tap the profits in exotic and obscure global markets
Opinion Peter Walls, manager of the Unicorn Mastertrust fund, highlights three investment trusts as he shares where he'd put his money
By Peter Walls
-
The star small and mid-cap stocks income investors have overlooked
Opinion Thomas Moore, senior investment director, Aberdeen, highlights three company stocks as he shares where he would put his money
By Thomas Moore
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge
-
Chemring Group: an explosive investment opportunity in defence
European states are raising their military spending, and Chemring Group looks well placed to profit
By Rupert Hargreaves
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs